M&A

Cortec Group Buys Cranial Technologies
Thu, 01/19/12 - 10:59 pm
Cortec Group
Cranial Technologies
M&A
Second confirmed bidder for Inhibitex bodes well for Idenix, says Wedbush
Yahoo/Fly on the Wall
Wed, 01/18/12 - 10:22 am
M&A
Bristol-Myers Squibb
Inhibitex
Jazz Pharmaceuticals and Azur Pharma Combine to Create Jazz Pharmaceuticals plc
Yahoo
Wed, 01/18/12 - 09:50 am
Jazz Pharmaceuticals
Azur Pharma
M&A
Terumo picks up Onset Corp. | Acquisitions Roundup
Tue, 01/17/12 - 10:54 pm
Terumo
Onset Therapeutics
M&A
Prolor Biotech: A Potentially Attractive Takeover Target
Seeking Alpha
Tue, 01/17/12 - 11:44 am
Prolor
M&A
Valeant Raises Bid for Ista Pharmaceuticals to $7.50 a Share
Bloomberg
Tue, 01/17/12 - 10:09 am
Valeant Pharmaceuticals
Ista
M&A
Bristol-Myers Raised Inhibitex Offer 30%
Bloomberg
Sat, 01/14/12 - 11:40 am
Bristol-Myers Squibb
Inhibitex
M&A
CEO Gaffe of the Week: Bristol-Myers Squibb
Motley Fool
Sat, 01/14/12 - 11:35 am
Bristol-Myers Squibb
Inhibitex
M&A
Zimmer Acquires Synvasive Tech.
Sat, 01/14/12 - 11:34 am
Zimmer
Synvase Technology
M&A
Onyx Pharma CFO plugs cancer pipeline amid rumored sales process
Fierce Biotech
Fri, 01/13/12 - 09:29 am
ONYX Pharmaceuticals
Pfizer
Takeda
M&A
cancer
Nexavar
Bristol-Myers Squibb Begins Tender Offer to Acquire Inhibitex, Inc.
Yahoo
Fri, 01/13/12 - 09:27 am
Inhibitex
tender offer
M&A
Bristol-Myers Squibb
AtriCure again cited by an analyst as likely acquisition target
Thu, 01/12/12 - 11:00 pm
ArtiCure
M&A
Inhibitex Shareholders Sue Over Bristol’s $2.5 Billion Offer
Bloomberg
Thu, 01/12/12 - 10:07 pm
shareholders
M&A
Inhibitex
Bristol-Myers Squibb
Europe’s Drugmakers May Boost Acquisitions After Buyback Focus
Bloomberg Businessweek
Thu, 01/12/12 - 02:11 pm
Europe
M&A
patents
GSK
Roche
AstraZeneca
Novartis
Abbott says no bid on rival Pfizer's baby, infant nutrition business
Crain's Chicago Business, IL
Thu, 01/12/12 - 09:17 am
Abbott Laboratories
infant nutrition
Pfizer
M&A
Gilead nears completion of Pharmasset deal
Yahoo/AP
Thu, 01/12/12 - 08:29 am
M&A
Pharmasset
Gilead
Boston Scientific CEO says sees significant future capacity for acquisitions
Wed, 01/11/12 - 10:40 pm
Boston Scientific
CEO
M&A
$3B or less is Big Pharma's M&A sweet spot
Fierce Pharma
Wed, 01/11/12 - 12:58 pm
M&A
Roche
Sanofi
Bristol-Myers Squibb
Novartis
Pfizer
Merck
Sanofi CEO Is Open to Deals of Up to $2.6 Billion This Year
Bloomberg
Wed, 01/11/12 - 10:55 am
Sanofi
Pharma CEOs
M&A
Chris Viehbacher
A White Hot Hep C Market: What The Wags Say
Pharmalot
Mon, 01/9/12 - 01:24 pm
hepatitis C
Inhibitex
Bristol-Myers Squibb
Gilead
Pharmasset
M&A

Pages